MRSA Infection Clinical Trial
Official title:
Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole (TMP-SMX) Plus Rifampicin With a Regimen of Linezolid in the Treatment of Infections Caused by Methicillin-resistant Staphylococcus Aureus (MRSA)
MRSA infections often require systemic antibiotic therapy and represent an important healthcare burden. Currently available treatment options are either only available in parenteral form (vancomycin) or expensive (linezolid). Thus, there is an urgent, unmet need to better investigate in-expensive but highly active alternatives to currently recommended standard treatment options. The purpose of the proposed study is to test the hypothesis that a combination of TMP-SMX and rifampicin is not inferior to linezolid for treatment of MRSA infections.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00448942 -
The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections
|
N/A | |
| Completed |
NCT00685867 -
Two Strategies for Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Prevention in Surgical Patients
|
N/A | |
| Withdrawn |
NCT00790972 -
The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity
|
N/A | |
| Withdrawn |
NCT00766259 -
Relationship of Staphylococcal Colonization to Infection
|
||
| Completed |
NCT00731783 -
Staphylococcus Aureus Decolonization Study
|
N/A | |
| Not yet recruiting |
NCT01724671 -
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
|
N/A | |
| Recruiting |
NCT00502476 -
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
|
N/A | |
| Completed |
NCT01814371 -
Individualized vs. Household MRSA Decolonization
|
N/A |